Could a biobank unlock secrets of rare kidney stone diseases?
NCT ID NCT02026388
First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time
Summary
This study creates a biobank of blood, urine, and tissue samples from people with rare kidney stone diseases—primary hyperoxaluria, cystinuria, APRT deficiency, and Dent disease—and their family members. By storing these samples, researchers hope to enable future studies that could improve diagnosis and treatment. The goal is to build a resource that helps scientists better understand these rare conditions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this biobank could provide a valuable resource for researchers studying rare kidney stone diseases, potentially leading to better understanding and new treatments.
- What could go wrong
- This is a biobank study, not a treatment trial. It collects samples for future research, so it does not directly test any therapy or provide immediate benefit to participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APRT DEFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Global registry aims to crack the code of rare kidney stone diseases
- Natural supplement aims to stop painful kidney stones
- Cystinuria drug trial pulled before it even started
- Could a diabetes drug stop painful kidney stones?
- Promising drug may protect kidneys in kids with rare oxalate disorder
- Sound waves may replace X-Rays for dental implant timing